"10.1371_journal.pone.0046432","none","2012-10-23T00:00:00Z","Hideo Yoshida; Yuka Ashikawa; Shinsuke Itoh; Takashi Nakagawa; Akimune Asanuma; Sohei Tanabe; Yoshihiro Inoue; Hiroyoshi Hidaka","Tokyo New Drug Research Laboratories, Kowa Company, Ltd., Tokyo, Japan; D. Western Therapeutics Institutes, Inc., Nagoya, Japan","Conceived and designed the experiments: HY YA SI YI HH. Performed the experiments: HY YA SI YI. Analyzed the data: HY YA SI AA ST YI. Wrote the paper: HY SI TN.","HY, YA, SI, TN, AA, and ST are employees of Kowa Company, Ltd. YI and HH is an employee and founder of D. Western Therapeutics Institutes, Inc., respectively. Kowa Company has been developing K-134 as a drug for the treatment of intermittent claudication. D. Western therapeutics institutes, Inc. and Kowa Company, Ltd. have a patent associated with K-134 (WO/97/12869). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Hideo Yoshida","HY",8,TRUE,5,4,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
